Binding affinities on all scales from fragment screening to intrinsically disordered proteins with isothermal spectral shift technology

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

March 30, 2028
Response Due
Active
Status

Opportunity Overview

The precise characterisation of biomolecular interactions, their binding constants and stoichiometries, lie at the heart of understanding events in cells and disease. Furthermore, the discovery and development of new drugs often requires the screening of chemical libraries containing hundreds if not many thousands of chemical compounds. After a small number of hit compounds are discovered, the optimisation towards a promising lead compound is greatly aided by a precise knowledge of their binding to their biological targets. Among the many different screening technologies, biophysical techniques that precisely measure the strength of the binding (binding constant Kd) and the composition of the complex (stoichiometry) are often considered the gold standard. However, many therapeutic targets are challenging and some are still entirely within the reach of current biophysical techniques. These include many membrane proteins that cannot be produced at the required amount or concentration. The Dianthus by NanoTemper Technologies, based on a novel spectral shift technology, represents a huge leap in sensitivity which enables the precise measurement of binding constants in very small volumes (less than five microliter) and at very low (nanomolar) concentrations. Hence, analyses of the most challenging protein targets, such as membrane proteins that often require detergents and intrinsically disordered proteins that tend to precipitate even at moderate concentrations, become feasible. Furthermore, combining this technology with high-throughput methods allows the measurements of 384 wells in parallel in less than one hour, which allows the screening of entire chemical libraries with thousands of compounds. Importantly, the Dianthus system will be the centre piece of the biophysical screening platform at the Biophysical Sciences Institute at Durham University which includes a wide range of complementary instrumentation. Taken together with the technical and scientific...

This is one of 1,833 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedNovember 01, 2022
Procurement stageActive solicitation
Response dueMarch 30, 2028
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

MRC CoRE in Restorative Immunology
Ultraprocessed foods: mechanisms of harm and harm reduction
Dectin-1-mediated suppression of protective anti-mycobacterial immunity
Iron and immunity
Development and pilot of a novel digital puberty self-assessment tool
Targeting the circadian clock to restore hepatitis B T-cell immunity
The mechanistic basis for the ZAP antiviral system targeting viral and cellular RNAs
Mutagenesis and its biomedical consequences

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.